(Q45258281)
English
Phase I/II study of the rituximab-EPOCT regimen in combination with granulocyte colony-stimulating factor in patients with relapsed or refractory follicular lymphoma including evaluation of its cardiotoxicity using B-type natriuretic peptide and tro
scientific article published in January 2005
Statements
1 reference
Phase I/II study of the rituximab-EPOCT regimen in combination with granulocyte colony-stimulating factor in patients with relapsed or refractory follicular lymphoma including evaluation of its cardiotoxicity using B-type natriuretic peptide and tro (English)
1 reference
Nozomi Niitsu
1 reference
Mika Khori
1 reference
Miyuki Hayama
1 reference
Koichi Kajiwara
1 reference
Masaaki Higashihara
1 reference
Jun-ichi Tamaru
1 reference
1 January 2005
1 reference
1 reference
11
1 reference
2 Pt 1
1 reference
697-702
1 reference
Identifiers
1 reference